Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33822368/

doi: 10.1111/bjh.17435. Online ahead of print. 1 Vejle Hospital and University of Southern Denmark, Vejle, Denmark. 2 National and Kapodistrian University of Athens School of Medicine, Athens, Greece. 3 Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain. 4 Clinica Universidad de Navarra, Pamplona, Spain.